Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Predicts Response to Exposure Therapy in Posttraumatic Stress Disorder

(2013) Kim L. Felmingham et al.   BIOLOGICAL PSYCHIATRY

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

(2013) Undine E. Lang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa)

(2013) Li-Ming Zhang et al.   NEUROPHARMACOLOGY

Longitudinal Changes in Serum Brain-Derived Neurotrophic Factor in Accident Survivors with Posttraumatic Stress Disorder

(2013) Yutaka Matsuoka et al.   NEUROPSYCHOBIOLOGY

Repeated administration of AC-5216, a ligand for the 18kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder

(2013) Zhi-Kun Qiu et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Avoiding Serotonin Syndrome: The Nature of the Interaction Between Tramadol and Selective Serotonin Reuptake Inhibitors

(2012) Elana M Nelson et al.   ANNALS OF PHARMACOTHERAPY

Considerations on Safety Concerns About Citalopram Prescribing

(2012) Robert D. Sheeler et al.   MAYO CLINIC PROCEEDINGS

Gene × environment vulnerability factors for PTSD: The HPA-axis

(2011) Divya Mehta et al.   NEUROPHARMACOLOGY

The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in posttraumatic stress disorder

(2011) Nela Pivac et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice

(2010) Francisca Charliane Carlos da Silva et al.   BRAIN RESEARCH BULLETIN

Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine

(2010) Kenji Hashimoto   Expert Review of Neurotherapeutics

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

(2010) N. Li et al.   SCIENCE

Glutamatergic Modulators: The Future of Treating Mood Disorders?

(2010) Carlos Zarate et al.   HARVARD REVIEW OF PSYCHIATRY

Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models

(2009) E. Engin et al.   NEUROSCIENCE

Ketamine and the next generation of antidepressants with a rapid onset of action

(2009) Rodrigo Machado-Vieira et al.   PHARMACOLOGY & THERAPEUTICS

A NMDA Receptor Antagonist, MK-801 Impairs Consolidating Extinction of Auditory Conditioned Fear Responses in a Pavlovian Model

(2009) Jun-Li Liu et al.   PLoS One

Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder

(2009) Liliana Dell'Osso et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Chronic Administration of Ketamine Elicits Antidepressant-Like Effects in Rats without Affecting Hippocampal Brain-Derived Neurotrophic Factor Protein Levels

(2008) Lêda S. Garcia et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Glutamate and cortisol—a critical confluence in PTSD?

(2008) JMHM Reul et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Correlation Between Ketamine and Posttraumatic Stress Disorder in Burned Service Members

(2008) Laura L. McGhee et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

(2007) Sungho Maeng et al.   BIOLOGICAL PSYCHIATRY

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

(2007) Lêda S.B. Garcia et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY